AldermanCP. Possible interaction between nefazodone and pravastatin (letter). Ann Pharmacother1999;33: 871.
2.
Expert Panel on Detection, Evaluation, Treatment of High Blood Cholesterol in Adults, National Cholesterol Education Program. Second report of the Expert Panel on Detection, Evaluation, Treatment of High Blood Cholesterol in Adults. Adult Treatment Panel II. Circulation1994;89;1329–445.
3.
SpraycarM, ed. Stedman's medical dictionary. 26th ed. Baltimore: Williams & Wilkins, 1995.
4.
JacobsenWKirchnerGHallenslebenKMancinelliLDetersMHackbarthIComparison of cytochrome P450 dependent metabolism and drug interactions of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors lovastatin and pravastatin in the liver. Drug Metab Dispos1999;27:173–9.
5.
RegazziMBIaconaICampagnaCGavazziAViganoMPeraniG. Clinical efficacy and pharmacokinetics of HMG-CoA reductase inhibitors in heart transplant patients treated with cyclosporin A. Transplant Proc1994;26: 2644–5.
6.
QuionJAJonesPH. Clinical pharmacokinetics of pravastatin. Clin Pharmacokinet1994;27: 97–103.
7.
LennernasHFagerG. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors — Similarities and differences. Clin Pharmacokinet1997;32: 403–25.
